X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (12) 12
humans (10) 10
adult (8) 8
hematology (8) 8
female (7) 7
treatment outcome (7) 7
male (6) 6
middle aged (6) 6
oncology (6) 6
aged (5) 5
aged, 80 and over (5) 5
leukemia (5) 5
cancer (4) 4
care and treatment (4) 4
chemotherapy (4) 4
adolescent (3) 3
analysis (3) 3
clinical trials (3) 3
stem cell transplantation (3) 3
stem cells (3) 3
transplantation (3) 3
acute myeloid-leukemia (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic agents - pharmacology (2) 2
antineoplastic agents - therapeutic use (2) 2
autografts (2) 2
cells (2) 2
chronic myeloid leukemia (2) 2
dasatinib - adverse effects (2) 2
dasatinib - therapeutic use (2) 2
double-blind (2) 2
drug therapy, combination (2) 2
efficacy (2) 2
febrile neutropenia (2) 2
fusion proteins, bcr-abl - genetics (2) 2
hematology, oncology and palliative medicine (2) 2
hematopoietic stem cells (2) 2
hemopoiesis (2) 2
leukocytes, mononuclear - metabolism (2) 2
lymphoma (2) 2
lymphomas (2) 2
medical colleges (2) 2
medicine & public health (2) 2
myelodysplastic syndromes - drug therapy (2) 2
patients (2) 2
prognosis (2) 2
protein kinase inhibitors - adverse effects (2) 2
protein kinase inhibitors - therapeutic use (2) 2
reverse transcriptase polymerase chain reaction (2) 2
t cells (2) 2
1-beta-d-arabinofuranosylcytosine (1) 1
1st complete remission (1) 1
2-year follow-up (1) 1
5'-nucleotidase - biosynthesis (1) 1
5'-nucleotidase - genetics (1) 1
800 mg (1) 1
acute disease (1) 1
acute leukemia (1) 1
acute promyelocytic leukemia (1) 1
aids (1) 1
aiha (1) 1
akt inhibitor (1) 1
anemia, hemolytic, autoimmune - drug therapy (1) 1
anemia, hemolytic, autoimmune - virology (1) 1
angioimmunoblastic t-cell lymphoma (1) 1
anti-bacterial agents - therapeutic use (1) 1
anti-infective agents - therapeutic use (1) 1
antifungal agents - therapeutic use (1) 1
antigens, cd34 - metabolism (1) 1
antimetabolites, antineoplastic - therapeutic use (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents - pharmacokinetics (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
apoptosis (1) 1
apoptosis - drug effects (1) 1
article subject (1) 1
autologous stem cell transplantation (1) 1
azathioprine (1) 1
b-cell lymphoma (1) 1
bacterial toxins - analysis (1) 1
bcr-abl activity (1) 1
biomedicine (1) 1
blast cells (1) 1
blood (1) 1
blotting, western (1) 1
bone marrow cells - metabolism (1) 1
breakpoint (1) 1
cancer chemopreventive activity (1) 1
carboplatin (1) 1
case report (1) 1
cd34 (1) 1
cd56 (1) 1
cd56 antigen - metabolism (1) 1
cefepime (1) 1
ceftazidime plus amikacin (1) 1
cell line (1) 1
cell proliferation - drug effects (1) 1
cell research (1) 1
cell survival (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
European Journal of Clinical Pharmacology, ISSN 0031-6970, 2/2016, Volume 72, Issue 2, pp. 185 - 193
Dasatinib is a novel, oral, multi-targeted kinase inhibitor of breakpoint cluster region-abelson (BCR-ABL) and Src family kinases. The study investigated... 
Dasatinib | Pharmacodynamics | Biomedicine | Half maximal inhibitory concentration | Phamacokinetics | Pharmacology/Toxicology | Molecular response | CELLS | SAFETY | TYROSINE KINASE | NILOTINIB | PHILADELPHIA-CHROMOSOME | IMATINIB | DRUGS | BCR-ABL ACTIVITY | PHARMACOLOGY & PHARMACY | INHIBITOR | Leukocytes, Mononuclear - metabolism | Antigens, CD34 - metabolism | Oncogene Protein v-crk - antagonists & inhibitors | Humans | Middle Aged | Oncogene Protein v-crk - metabolism | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Dasatinib - pharmacokinetics | Male | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Antineoplastic Agents - pharmacokinetics | Antineoplastic Agents - pharmacology | Phosphorylation - drug effects | Protein Kinase Inhibitors - pharmacokinetics | Leukocytes, Mononuclear - drug effects | Dasatinib - therapeutic use | Treatment Outcome | Dasatinib - pharmacology | Fusion Proteins, bcr-abl - genetics | Protein Kinase Inhibitors - therapeutic use | Fusion Proteins, bcr-abl - antagonists & inhibitors | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - metabolism | Aged | Dasatinib - adverse effects | Protein Kinase Inhibitors - pharmacology | Phosphotransferases | Analysis | Chronic myeloid leukemia | Pharmacology | Kinetics | Drug therapy | Leukemia | Chronic illnesses | Index Medicus
Journal Article
Annals of Oncology, ISSN 0923-7534, 11/2015, Volume 26, Issue suppl 7, pp. vii85.2 - vii85
Journal Article
Journal Article
European Journal of Haematology, ISSN 0902-4441, 01/2018, Volume 100, Issue 1, pp. 27 - 35
Journal Article
Annals of Oncology, ISSN 0923-7534, 10/2014, Volume 25, Issue suppl_5, pp. v61 - v61
Journal Article
Annals of Oncology, ISSN 0923-7534, 10/2014, Volume 25, Issue suppl_5, pp. v82 - v83
Journal Article
Annals of Oncology, ISSN 0923-7534, 11/2015, Volume 26, Issue suppl 7, pp. vii109.4 - vii109
Journal Article
Annals of Oncology, ISSN 0923-7534, 10/2014, Volume 25, Issue suppl_5, pp. v42 - v42
Journal Article
Journal Article
[Rinsho ketsueki] The Japanese journal of clinical hematology, ISSN 0485-1439, 08/2016, Volume 57, Issue 8, p. 1011
Recent advances in surgical corrections and supportive care for congenital heart disease have resulted in increasing numbers of adult survivors who may develop... 
Precursor Cell Lymphoblastic Leukemia-Lymphoma - complications | Heart Defects, Congenital - complications | Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy | Humans | Adult | Female | Treatment Outcome | Cord Blood Stem Cell Transplantation
Journal Article
[Rinsho ketsueki] The Japanese journal of clinical hematology, ISSN 0485-1439, 08/2016, Volume 57, Issue 8, pp. 1011 - 1017
Journal Article
Scandinavian Journal of Gastroenterology, ISSN 0036-5521, 2009, Volume 44, Issue 1, pp. 74 - 78
Journal Article
Case reports in hematology, ISSN 2090-6560, 2013, Volume 2013, pp. 651902 - 5
Novel agents such as thalidomide, lenalidomide, and bortezomib have been shown to possess potent activity against multiple myeloma. However, the treatment... 
Case Report
Journal Article
Leukemia Research, ISSN 0145-2126, 2007, Volume 31, Issue 10, pp. 1343 - 1349
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.